Mitchell Kim, MD
Sports Medicine · Eatontown, NJNPI 1144752122
Payments from drug & device makers
Across 56 payments — averaging $18.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$148
- Bioventus LLC$143
- AbbVie$123
- Ferring Pharmaceuticals Inc.$98
- Avanos Medical$81
- Biohaven Pharmaceutical Holding Company Ltd.$49
- plus $394 from 17 others
What the payments were for
- Food & beverage$1,035100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 10 | $148 |
| Bioventus LLC | 4 | $143 |
| AbbVie | 8 | $123 |
| Ferring Pharmaceuticals Inc. | 5 | $98 |
| Avanos Medical | 3 | $81 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $49 |
| Johnson & Johnson | 2 | $39 |
| Bayer | 2 | $39 |
| Merz Pharmaceuticals, LLC | 2 | $33 |
| AstraZeneca | 2 | $30 |
| GSK | 2 | $28 |
| Electronic Waveform Lab, Inc. | 1 | $28 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
| Dynavax Technologies Corporation | 2 | $26 |
| Exact Sciences | 1 | $22 |
| IBSA Pharma Inc. | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Novartis | 1 | $16 |
| Scilex Pharmaceuticals Inc. | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
How this compares
$1,035 in reported general payments places this provider in the 45th percentile of 221 sports medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 11 | $11 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Eatontown
- Sean McMillanBurlington$2.9M
- Nicholas JarmonFreehold$277K
- Thomas YoumEnglewood$222K
- Michael ShindleWayne$141K
- Bradford TuckerEgg Harbor Township$87K
- Robin GehrmannNewark$80K
- Anthony PetrosiniManasquan$78K
- Stephen HuntCedar Knolls$76K
- David PorterHackensack$65K
- Francis AlbertaHackensack$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.